Related Experiment Videos
Ursodeoxycholic acid has no influence on function after restorative proctocolectomy in ulcerative colitis
1University Department of Surgery, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.
Alimentary Pharmacology & Therapeutics
|December 14, 1999
Summary
Ursodeoxycholic acid therapy did not improve pouch function or bowel frequency in ulcerative colitis patients with poor pouch function. This bile acid replacement therapy showed no significant benefit over placebo in the short-term study.
Area of Science:
- Gastroenterology
- Surgical Outcomes
- Bile Acid Metabolism
Background:
- Poor pouch function after restorative proctocolectomy for ulcerative colitis is linked to impaired bile acid absorption and increased fecal bile acid loss.
- Bile acid replacement therapy is a potential treatment, but its efficacy is uncertain due to potential aggravation of diarrhea.
Purpose of the Study:
- To evaluate the effectiveness of exogenous bile acid therapy in patients experiencing poor pouch function post-restorative proctocolectomy for ulcerative colitis.
Main Methods:
- A prospective, randomized, double-blind, placebo-controlled crossover trial was conducted.
- Twenty ulcerative colitis patients with poor pouch function were treated with ursodeoxycholic acid (10 mg/kg/day) or placebo for one month each.
Main Results:
- Sixteen patients completed the study.
- No statistically significant differences in pouch function scores or bowel frequency were observed between ursodeoxycholic acid treatment and placebo.
Conclusions:
- Short-term (4-week) administration of ursodeoxycholic acid does not appear to influence functional outcomes or bowel frequency in patients with poor pouch function following restorative proctocolectomy for ulcerative colitis.